RecruitingNot applicableNCT05930093

Evaluate the Efficacy and Safety of LivPhcD Capsules in the NAFLD Subjects

Studying Cap myopathy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
TCM Biotech International Corp.
Intervention
Placebo(dietary_supplement)
Enrollment
108 enrolled
Eligibility
20-75 years · All sexes
Timeline
20232026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05930093 on ClinicalTrials.gov

Other trials for Cap myopathy

Additional recruiting or active studies for the same condition.

See all trials for Cap myopathy

← Back to all trials